Loading

Data and information related to Global Fund grants has moved and is now available on the Data Explorer. Please use this site.

Overview

The Philippines has made big gains in the fight against HIV, tuberculosis and malaria.

Malaria is in retreat, with a 79 percent reduction in new cases between 2010 and 2017. The country is now on a path to malaria elimination by 2030.

At less than 1 percent, HIV prevalence remains relatively low. However, the Philippines has the fastest-growing HIV epidemic in the Asia-Pacific region. Men who have sex with men, transgender women, and people who inject drugs face challenges in accessing much-needed prevention and treatment services. In order to stop the spread of the disease in the country, Global Fund investments focus on key populations through expanded outreach and case finding, testing, condoms distribution, and funding programs that remove human rights barriers to accessing HIV services.

The Philippines has also made positive strides in confronting TB through increased case notification, maintaining a high treatment success for Drug Susceptible TB and registering over a 100 percent increase in the number of MDR-TB patients put on treatment. From 2014 to 2017, Global Fund grants have supported the Philippines TB program to notify and enrol more than 17,000 MDR-TB patients. But the burden still remains high, with 200,000 missing TB cases that threaten to undermine the gains achieved. The Global Fund continues its commitment to supporting TB elimination in the Philippines by investing in innovative approaches to find the missing cases of the disease while maintaining current levels of effort and quality of treatment.

Documentation

Country documentation available on the Data Explorer

For documents pertaining to a specific grant, please select a grant from the list.